We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Neuroendoscopy System Improves Outcome of Minimally Invasive Neurosurgical Procedures

By HospiMedica International staff writers
Posted on 02 Sep 2024
Print article
Image: The Neuroblade System has received FDA clearance (Photo courtesy of Clearmind Biomedical)
Image: The Neuroblade System has received FDA clearance (Photo courtesy of Clearmind Biomedical)

A new neuroendoscopy system integrates various features such as visualization, illumination, irrigation, suction, coagulation, and powered debridement to enable minimally invasive procedures.

The Neuroblade System by Clearmind Biomedical (San Jose, CA, USA) consists of three main components: the Neuroblade, a single-use, multifunctional neuroendoscope; the Neuropad, a reusable medical-grade tablet; and Clearpath, a disposable transparent access sheath. The system displays camera images on the Neuropad via a cable from the Neuroblade, which also has integrated irrigation and aspiration capabilities. Its distal bipolar electrode allows for the use of RF energy from a third-party RF generator for vessel coagulation in the neuro space, and a cutting window at the distal end aids in blood clot removal. The Neuroblade System is inserted into the brain through a burr hole in the patient’s skull.

This system is designed to enhance the efficiency and outcomes of minimally invasive neurosurgical operations. The Neuroblade system provides a significant advancement in the surgical management of intracerebral hemorrhage. Its design simplifies the operating room setup and combines critical functions in one device, potentially enhancing patient outcomes. In its first U.S. application, the Neuroblade was used in an emergency operation to remove a hemorrhagic stroke. The Clearpath sheath facilitated precise access to the affected area, while the Neuroblade delivered comprehensive capabilities including real-time visualization and tools for suction, irrigation, powered debridement, and coagulation. The Neuroblade System has been granted FDA 510(k) clearance for use in illuminating and visualizing intracranial tissues and fluids, controlled aspiration of tissue and/or fluids, powered soft tissue cutting, and tissue coagulation under direct visualization during surgery in the ventricular system or cerebrum.

"FDA clearance and the first U.S. surgery mark significant milestones for the Neuroblade System, which we believe will revolutionize minimally invasive neurosurgery,” said J. Dustin Duckett, Clearmind's Vice President and General Manager for the Americas. “Developed with input from surgeons, Neuroblade's integrated features aim to enhance surgical efficiency and patient outcomes. We look forward to further developing evidence, driving adoption, and ultimately getting more patients access to desperately needed care."

Related Links:
Clearmind Biomedical

Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Transportation Stretcher
ES709
New
Pediatric Phlebotomy Chair
2665M2 Extra Wide Pediatric Phlebotomy Chair

Print article

Channels

Critical Care

view channel
Image: Associate Professor Lisa Zhu and Wenyi Hu investigated the use of an AI eye test in GP clinics (Photo courtesy of CERA)

AI Eye Scans Could Help Identify Heart Disease and Stroke Risk

New research has explored the advantages of utilizing artificial intelligence (AI) retinal imaging for screening cardiovascular diseases in general practice (GP) clinics and highlighted areas where improvements... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.